Allison Portnoy, ScD
Assistant Professor
Boston University School of Public Health
Global Health

ScD, Harvard School of Public Health

Pronouns: she/her/hers



Dr. Allison Portnoy is an assistant professor of global health focused on vaccine decision science and policy. Her research includes economic evaluation and public health policy, simulation modeling, health equity, and the impact of vaccination on population health and economic outcomes. She is particularly interested in broadening the value of vaccination in high-burden settings. Her ongoing work spans multiple diseases areas, including human papillomavirus (HPV), measles, and tuberculosis (TB).

Dr. Portnoy received a Doctor of Science from the Department of Global Health and Population and completed a postdoctoral fellowship at the Center for Health Decision Science, both at the Harvard T.H. Chan School of Public Health. Her previous education includes an MSPH in Health Policy & Management from the Johns Hopkins Bloomberg School of Public Health and a BA in International Relations from Stanford University. She previously worked as a health economist at the International Vaccine Access Center at Johns Hopkins, and conducted research projects with the World Health Organization, Agency for Healthcare Research and Quality, and the University of Washington in Seattle.


Vaccine Impact Modelling Consortium (VIMC) 2.0
07/01/2023 - 08/31/2027 (Subcontract PI)
Imperial College Gavi Vaccine Ally


Costs of Delivering Vaccines to Zero-dose Children
03/11/2024 - 10/31/2025 (PI)
Gavi, the Vaccine Alliance


Vaccine Impact Modelling Consortium (VIMC) (Task order 3)
09/23/2024 - 08/31/2025 (Subcontract PI)
Imperial College Bill & Melinda Gates


LSHTM M72 : Modelling the potential impact of M72/AS01E and BCG revaccination using a decision science framework
01/01/2024 - 12/31/2024 (Subcontract PI)
Harvard School of Public Health London Sch-Trop Med


Future needs for estimation of measles case fatality ratios (CFRs)
06/30/2023 - 09/30/2023 (Subcontract PI)
President and Fellows of Harvard College dba Harvard T.H. Chan School of Public Health Bill & Melinda Gates




Title


Yr Title Project-Sub Proj Pubs

Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.

iCite Analysis       Copy PMIDs To Clipboard

  1. Moghtaderi A, Callaghan T, Luo Q, Motta M, Tan TQ, Hillard L, Dor A, Portnoy A, Winter AK, Black B. Evidence on trends in uptake of childhood vaccines and association with COVID-19 vaccination rates. Vaccine. 2025; 45:126631. View Publication
  2. Moghtaderi A, Callaghan T, Luo Q, Motta M, Tan TQ, Hillard L, Dor A, Portnoy A, Winter A, Black B. Evidence on trends in uptake of childhood vaccines and association with COVID-19 vaccination rates. Vaccine. 2025 Jan 25; 45:126631.View Related Profiles. PMID: 39700909
     
  3. Shankar M, Hartner AM, Arnold CRK, Gayawan E, Kang H, Kim JH, Gilani GN, Cori A, Fu H, Jit M, Muloiwa R, Portnoy A, Trotter C, Gaythorpe KAM. How mathematical modelling can inform outbreak response vaccination. BMC Infect Dis. 2024 Dec 01; 24(1):1371. PMID: 39617902; PMCID: PMC11608489; DOI: 10.1186/s12879-024-10243-0;
     
  4. Lambach P, Silal S, Sbarra AN, Koh M, Aggarwal R, Farooqui HH, Flasche S, Hogan AB, Kim SY, Leung K, Moss WJ, Munywoki PK, Portnoy A, Sheel M, Wang XY. Report from the World Health Organization's immunization and vaccines-related implementation research advisory committee (IVIR-AC) meeting, virtual gathering, 10-13 September 2024. Vaccine. 2025 Jan 01; 43(Pt 2):126519. PMID: 39536476; PMCID: PMC11672236; DOI: 10.1016/j.vaccine.2024.126519;
     
  5. Burger EA, Laprise JF, Portnoy A, Spencer JC, Sy S, Regan MC, Bénard É, Drolet M, Brisson M, Kim JJ. Population-level health impact of hypothetical waning 1-dose human papillomavirus vaccination and 2-dose mitigation strategies in a high cervical cancer burden setting. J Natl Cancer Inst Monogr. 2024 Nov 01; 2024(67):379-386. PMID: 39529530; PMCID: PMC11555273; DOI: 10.1093/jncimonographs/lgae039;
     
  6. Lambach P, Silal S, Sbarra AN, Crowcroft NS, Frey K, Ferrari M, Vynnycky E, Metcalf CJE, Winter AK, Zimmerman L, Koh M, Sheel M, Kim SY, Munywoki PK, Portnoy A, Aggarwal R, Farooqui HH, Flasche S, Hogan AB, Leung K, Moss WJ, Wang XY. Report from the World Health Organization's immunization and vaccines-related implementation research advisory committee (IVIR-AC) ad hoc meeting, 28 June - 1 July 2024. Vaccine. 2024 Dec 02; 42(26):126307. PMID: 39276622; PMCID: PMC11672238; DOI: 10.1016/j.vaccine.2024.126307;
     
  7. Gaythorpe KAM, Li X, Clapham H, Dansereau E, Fitzjohn R, Hinsley W, Hogan D, Jit M, Mengistu T, Perkins TA, Portnoy A, Vynnycky E, Woodruff K, Ferguson NM, Trotter CL. Estimating the impact of vaccination: lessons learned in the first phase of the Vaccine Impact Modelling Consortium. Gates Open Res. 2024; 8:97. PMID: 39398325; PMCID: PMC11467163; DOI: 10.12688/gatesopenres.15556.1;
     
  8. Lambach P, Silal S, Sbarra AN, Koh M, Aggarwal R, Farooqui HH, Flasche S, Hogan AB, Kim SY, Leung K, Moss WJ, Munywoki PK, Portnoy A, Sheel M, Wang XY. Corrigendum to "Report from the World Health Organization's immunization and vaccines-related implementation research advisory committee (IVIR-AC) meeting, virtual gathering, 26 February-1 March 2024" [Vaccine 42(15) (2024) 3379-3383]. Vaccine. 2024 Oct 03; 42(23):126102. PMID: 38991915; PMCID: PMC11413483; DOI: 10.1016/j.vaccine.2024.07.003;
     
  9. Clarke-Deelder E, Suharlim C, Chatterjee S, Portnoy A, Brenzel L, Ray A, Cohen JL, Menzies NA, Resch SC. Health impact and cost-effectiveness of expanding routine immunization coverage in India through Intensified Mission Indradhanush. Health Policy Plan. 2024 Jun 03; 39(6):583-592. PMID: 38590052; PMCID: PMC11145919; DOI: 10.1093/heapol/czae024;
     
  10. Clark RA, Portnoy A, Weerasuriya CK, Sumner T, Bakker R, Harris RC, Rade K, Mattoo SK, Tumu D, Menzies NA, White RG. Estimating the potential health and economic impacts of new tuberculosis vaccines under varying delivery strategies in Delhi and Gujarat, India: a modelling study. Lancet Reg Health Southeast Asia. 2024 Dec; 31:100424. PMID: 39957772; PMCID: PMC11827003; DOI: 10.1016/j.lansea.2024.100424;
     
Showing 10 of 65 results. Show More

This graph shows the total number of publications by year, by first, middle/unknown, or last author.

Bar chart showing 65 publications over 11 distinct years, with a maximum of 15 publications in 2024

YearPublications
20141
20152
20163
20173
20192
20205
202112
20229
202312
202415
20251

Note: X.com has changed/limited the ability to embed tweets directly in external sites and we are investigating ways to restore that functionality in BU Profiles. In the meantime we are displaying a link to your x.com profile in the Websites section above.

2023 International Papillomavirus Society: Early Career Recognition Award
2019 Harvard T.H. Chan School of Public Health: Clarence James and Sarah Bradley Gamble Scholarship
2019 Harvard T.H. Chan School of Public Health: Michael von Clemm Traveling Fellowship
2018 Harvard T.H. Chan School of Public Health: Uwe Brinkmann Memorial Travel Fellowship
2013 The National Board of Public Health Examiners: Certified in Public Health
2013 Johns Hopkins Bloomberg School of Public Health: Certificate in Vaccine Science and Policy
Contact for Mentoring:

801 Massachusetts Ave
Boston MA 02118
Google Map


Portnoy's Networks
Click the "See All" links for more information and interactive visualizations
Concepts
_
Co-Authors
_
Similar People
_
Same Department